Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Identification Of New Asthma Genes Demonstrates A Model For Improved Patient Care

13.04.2004


An international team of researchers from the University of Helsinki, GeneOS Ltd. and partner institutions announced today that it has made significant discoveries on the causes of asthma. The team’s study, published in the April 9, 2004 edition of Science, reports two novel asthma genes and a set of diagnostic single nucleotide polymorphisms (SNPs).

The implications of the finding are that physicians may be able to identify atopic asthma and allergy patients earlier than is currently possible. Even more importantly, the gene that was found to be the risk gene for asthma is well suited for a drug target molecule.
Previous genome-wide scans in multiple populations have suggested that there is a susceptibility region for asthma on chromosome 7p. This study focused its efforts to confirm the hypothesis and to identify the genes in the Finnish families. The results were then replicated among the Canadian families to be sure that the findings are valid also in other populations. A hierarchical genotyping design was used and lead to the identification of a 133kb risk-conferring segment that contained two genes. The data imply that an orphan G-protein receptor named GPRA is involved in the pathogenesis of atopy and asthma and may have application in other inflammatory diseases.


“The importance of this discovery is that our findings validate our approach of being able to build relevant patient databases and use this information to understand disease outcome”, said Tarja Laitinen, Chief Scientific Officer, GeneOS. “Additionally, these findings are very relevant for our company because they show how we can use information generated in Finland and apply it to other populations. GeneOS is building its capabilities to study disease outcomes in Finland to help pharmaceutical and medical device companies design and run clinical trials and better understand patient response. Findings like the GPRA gene will lead to better diagnosis and treatment.”

“This research is a culmination of ten-year project to identify genes for complex diseases”, said Professor Juha Kere from Karolinska Institutet (Sweden) and University of Helsinki. “Other, similar findings may become reality from comparable efforts, building on the excellent Finnish and Scandinavian medical and population data.”

The number of asthmatics has been growing at about 10 % per year; currently asthma affects approximately 6-10 % of the population in the United States and Western Europe. Asthma accounts for approximately 10 % of all prescription drug spending in the United States and Western Europe. Treatment plans are complex and the ability to measure improved outcome is poor. The ability to study outcomes in Finland and then confirm the findings in other populations will help improve treatment for patients worldwide.

For further information please contact:
Juha Kere, Professor, Helsinki University and Karolinska Institutet, +46 7 3421 3550, juha.kere@biosci.ki.se (about discovery)

Tarja Laitinen, Chief Scientific Officer, GeneOS Ltd., + 358 50 534 6238,tarja.laitinen@geneos.fi (about discovery and GeneOS)

Steve Lehrer, CEO, GeneOS Inc. +1 650 269 3420,
steve@sblehrer.com (about GeneOs)

Paivi Lehtinen | alfa
Further information:
http://www.helsinki.fi

More articles from Life Sciences:

nachricht Molecular evolution: How the building blocks of life may form in space
26.04.2018 | American Institute of Physics

nachricht Multifunctional bacterial microswimmer able to deliver cargo and destroy itself
26.04.2018 | Max-Planck-Institut für Intelligente Systeme

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Why we need erasable MRI scans

New technology could allow an MRI contrast agent to 'blink off,' helping doctors diagnose disease

Magnetic resonance imaging, or MRI, is a widely used medical tool for taking pictures of the insides of our body. One way to make MRI scans easier to read is...

Im Focus: BAM@Hannover Messe: innovative 3D printing method for space flight

At the Hannover Messe 2018, the Bundesanstalt für Materialforschung und-prüfung (BAM) will show how, in the future, astronauts could produce their own tools or spare parts in zero gravity using 3D printing. This will reduce, weight and transport costs for space missions. Visitors can experience the innovative additive manufacturing process live at the fair.

Powder-based additive manufacturing in zero gravity is the name of the project in which a component is produced by applying metallic powder layers and then...

Im Focus: Molecules Brilliantly Illuminated

Physicists at the Laboratory for Attosecond Physics, which is jointly run by Ludwig-Maximilians-Universität and the Max Planck Institute of Quantum Optics, have developed a high-power laser system that generates ultrashort pulses of light covering a large share of the mid-infrared spectrum. The researchers envisage a wide range of applications for the technology – in the early diagnosis of cancer, for instance.

Molecules are the building blocks of life. Like all other organisms, we are made of them. They control our biorhythm, and they can also reflect our state of...

Im Focus: Spider silk key to new bone-fixing composite

University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.

Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

World's smallest optical implantable biodevice

26.04.2018 | Power and Electrical Engineering

Molecular evolution: How the building blocks of life may form in space

26.04.2018 | Life Sciences

First Li-Fi-product with technology from Fraunhofer HHI launched in Japan

26.04.2018 | Power and Electrical Engineering

VideoLinks
Science & Research
Overview of more VideoLinks >>>